| mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
9e-07 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-06 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
| mRNA |
BAY 61-3606 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
8e-05 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
8e-05 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
8e-05 |